91AV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information

Making Medicines - from Laboratory to Pilot Plant Manufacture

13 November 2019 18:00-20:30, London, United Kingdom


Introduction
The journey of a successful medicine from discovery through development, to the treatment of patients is a long and complex process. One crucial aspect of this is the manufacture of the active pharmaceutical ingredient (API), with ever increasing quantities required from initially grams for safety testing, up to potentially thousands of kilograms for a commercial marketed medicine. This talk will provide a general overview of the development process. More detailed stories from the laboratory synthesis of potential medicines currently in the early stages of development, up to the large-scale manufacture of more advanced projects in a specialised Pilot Plant will also be shared. Focus and comparison on the changing technical, safety, accommodation and regulatory challenges during this journey will offer an engaging insight for all those interested in how medicines are made.

To register for a place at the lecture click on the Book Now button on this page.

 
Speakers
  • Dr James Douglas AstraZeneca, United Kingdom
  • Abi Thorne AstraZeneca, United Kingdom

Sponsorship & supporting organisations
Venue
Merck Sharp & Dohme Limited

Merck Sharp & Dohme Limited, Merck Sharp & Dohme Limited, 2 Pancras Square, London, N1C 4AG , United Kingdom

Organised by
The SCI London Regional Group
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*